XBI (SPDR S&P Biotech ETF) has now clearly taken out the 59.87 support level while IBB also broke below key support today. As such, it appears the correction in the biotechs is still well intact. IBB (iShares Nasdaq Biotech ETF) has broken below both the downtrend line & 268.20 support levels. As one of the top sectors in the Nasdaq 100, these support breaks in the biotech stocks does not bode well for the broad market.